{"id":"W2133193675","doi":"10.1634/theoncologist.12-7-785","title":"First-Line Treatment Options for Patients with HER-2–Negative Metastatic Breast Cancer: The Impact of Modern Adjuvant Chemotherapy","year":2007,"lang":"en","type":"review","venue":"The Oncologist","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"European Society for Medical Oncology; Pfizer","keywords":"Medicine; Metastatic breast cancer; Breast cancer; Adjuvant; Oncology; Adjuvant therapy; Clinical trial; Quality of life (healthcare); Chemotherapy; Cancer; Randomized controlled trial; Internal medicine; Intensive care medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004551009,0.0006058609,0.001525894,0.001427301,0.0002085512,0.0005919518,0.0006168625,0.00072714,0.002786455],"category_scores_gemma":[0.000672555,0.0001673903,0.0005444888,0.001356367,0.0002514439,0.0007849838,0.0002969248,0.001279855,0.001218744],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005241253,"about_ca_system_score_gemma":0.0007083606,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009333569,"about_ca_topic_score_gemma":0.002466206,"domain_scores_codex":[0.9998177,0.00004772672,0.00002360104,0.00002448068,0.00007464828,0.00001189014],"domain_scores_gemma":[0.9997156,0.0001614637,0.00004937381,0.000007531836,0.0000502724,0.00001576066],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005664914,0.0000673493,0.0001500836,0.01441999,0.00009586919,0.0001720061,0.00003167242,0.0003274091,0.000782591,0.001316939,0.01670536,0.965874],"study_design_scores_gemma":[0.00009174877,0.0002322598,0.002831311,0.01140363,0.0003456924,0.004343312,0.0001040741,0.0002530449,0.0007466571,0.002618795,0.9770027,0.00002668647],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000133571,0.9988129,0.00008763479,0.0002508315,0.00008200204,0.000003143244,0.000006909418,0.000003670572,0.0006194348],"genre_scores_gemma":[0.0006068835,0.9987743,0.0001494584,0.0001339643,0.00006465098,0.000003717541,0.00001009912,5.924751e-7,0.0002563659],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002786455,"threshold_uncertainty_score":0.00932163,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1131886795486073,"score_gpt":0.466774363464914,"score_spread":0.3535856839163067,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}